Register
ADA public policy statement on insulin access and affordability |
Journal Updates
eMediNexus Coverage from: 
ADA public policy statement on insulin access and affordability

0 Read Comments                

In a new public policy statement on insulin access and affordability released on May 24, 2018, the American Diabetes Association (ADA) recommends increasing transparency across the entire insulin supply chain; streamlining the approval process for biosimilar insulins, lowering or removing patient cost-sharing for insulin and increasing access to health care coverage for all people with diabetes.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now